Recro Pharma Inc.

(REPH) Trade

By |

Profile

Recro Pharma Inc is a specialty pharmaceutical company focused on products for hospitals and ambulatory care settings that develops non-opioid products for the treatment of acute pain. The company operates two divisions Acute Care division and a contract development and manufacturing or CDMO division. The Acute Care division is engaged in developing products for hospital and related settings. Its lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. The CDMO division develops and manufactures pharmaceutical products using the company's proprietary delivery technologies for commercial partners who commercialize or plan to commercialize these products. The majority of the company's revenue is generated from its CDMO segment.

Contact Information

Website: www.recropharma.com
Email: natalie@argotpartners.com
Main Phone: +1 484 395-2470
Address: 490 Lapp Road
Address 2: Suite 220
State: PA
City / Town: Malvern
Country: USA
Postal Code: 19355

Issuer Information

Exchange: NSC
CEO: Geraldine A. Henwood
Employees: 256
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 7.57 $ -0.21 (-2.70%)
Last Price 7.57 Change $ -0.21 Change % -2.70 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 7.80 High 7.80 Low 7.42 Prev Close 7.78
Last Trade Volume 58,517 52 Wk Hi 13.05 52 Wk Low 4.78
Market Cap 162.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 21,477,498.00 EPS (TTM) -3.18 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 20 54
Number of Buys 15 36
Number of Sells 5 18
Net Activity -53726 -38611
Last 10 Buys Shares
Wayne B. Weisman 1,000
Karen A. Flynn 1,000
Alfred Altomari 1,000
Wayne B. Weisman 1,000
Kevin Kotler 1,000
Kevin Kotler 1,000
Stewart McCallum 1,000
Fred Graff 1,000
Stewart McCallum 1,000
Randall Mack 1,000
Last 10 Sell Shares
Kevin Kotler 1,000
Kevin Kotler 1,000
Kevin Kotler 1,000
Kevin Kotler 1,000
Kevin Kotler 1,000
Kevin Kotler 1,000
Michael Berelowitz 1,000
Flynn E James 1,000
Flynn E James 1,000
Flynn E James 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 18 18 19 18
Low Target Price Estimate 8.5 8.5 8.5 8.5
Mean Target Price Estimate 11.63 11.63 11.88 11.63
Standard Deviation 4.39 4.39 4.87 4.39
Date of Most Recent Estimate 05/25/18 05/25/18 05/25/18 05/25/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1